Full text
2/2023
vol. 8
Original paper
Selected blood parameters with potential diagnostic application in the course of inflammation in chronically obese individuals undergoing bariatric surgery
- Katedra Geriatrii, Zakład Biochemii i Biogerontologii, Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Polska
- Katedra Higieny, Epidemiologii i Ergonomii i Kształcenia Podyplomowego, Uniwersytet Mikołaja Kopernika w Toruniu Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Polska
Long-Term Care Nursing 2023; 8 (2): 39-45
Data publikacji online: 2023/06/29
Article file
- WHO Fact Sheet: Obesity and overweight. Available at: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight Dostęp 30.04.2023
- World Obesity Day 2022 – Accelerating action to stop obesity. Available at: https://www.who.int/news/item/04-03-2022-world-obesity-day-2022-accelerating-action-tostop-obesity Dostęp 30.04.2023
- Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 14: 860-7
- Biobaku F, Ghanim H, Monte SV, Caruana JA, Dandona P. Bariatric Surgery: Remission of Inflammation, Cardiometabolic Benefits, and Common Adverse Effects. J Endocr Soc 2020; 4; 4(9).
- Ellulu MS, Patimah I, Khaza’ai H, i in. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci 2017; 13(4): 851–63.
- Goralska M, Majewska-Szczepanik M, Szczepanik M. Mechanizmy immunologiczne towarzyszące otyłości i ich rola w zaburzeniach metabolizmu. Postępy Higieny i Medycyny Doświadczalnej 2015; 69: 1384-1404.
- Rohm TV, Meier DT, Olefsky JM, Donath MY. Inflammation in obesity, diabetes, and related disorders. Immunity 2022: 55.1: 31-55.
- Scheithauer, Torsten PM, i in. Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes. Frontiers in immunology 2020; 2546.
- Ferraz-Bannitz R, Welendorf CR, Coelho PO, i in. Bariatric surgery can acutely modulate ER-stress and inflammation on subcutaneous adipose tissue in non-diabetic patients with obesity. Diabetol Metab Syndr 2021; 13(1): 1-11
- Sacks FM, Bray GA, Carey VJ, i in. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. Obstet Gynecol Surv 2009; p. 460–2.
- Caudwell P, Hopkins M, King NA, Stubbs RJ, Blundell JE. Exercise alone is not enough: weight loss also needs a healthy (Mediterranean) diet? Public Health Nutr 2009; 12(9A): 1663-6.
- Velazquez A, Apovian CM. Pharmacological management of obesity. Minerva Endocrinol. 2018; 356–66.
- Nguyen NT, Varela JE. Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol 2017; 160–9.
- Fred M, Heiner V, Basdevant A, i in. Wytyczne europejskie w zakresie chirurgicznego leczenia otyłości olbrzymiej. Endokrynol Otył Zab Przem Mat 2009; 5: 9.
- Kuczyńska B, Biczysko M, Bogdański P. Chirurgiczne leczenie otyłości olbrzymiej i zaburzeń metabolicznych. Forum Zaburzeń metabolicznych 2012; 3(2); 61-69.
- Welbourn R, Hollyman M, Kinsman R, i in. Bariatric surgery worldwide: baseline demographic description and one-year outcomes from the Fourth IFSO Global Registry Report 2018. Obes Surg 2019; 29(3): 782–95.
- Forsythe LK, Wallace JM, Livingstone MB. Obesity and inflammation: the effects of weight loss. Nutr Res Rev 2008; 21 :117–133.
- Askarpour M, Khani D, Sheikhi A, i in. Effect of Bariatric Surgery on Serum Inflammatory Factors of Obese Patients: a Systematic Review and Meta-Analysis. Obes Surg 2019; 29: 2631–2647.
- Lautenbach A, Stoll F, Mann O, i in. Long-term improvement of chronic low-grade inflammation after bariatric surgery. Obes Surg 2021; 5: 1–8.
- Huang J, Chen Y, Wang X, i in. Change in Adipokines and Gastrointestinal Hormones After Bariatric Surgery: a Metaanalysis. Obes Surg 2023; 33: 789–806
- El-Zawawy HT, El-Aghoury AA, Katri K M, i in. Cortisol/DHEA ratio in morbidly obese patients before and after bariatric surgery: Relation to metabolic parameters and cardiovascular performance. Int J Obes 2022; 46: 381–392.
- Oliveras A, Molina L, Goday A, i in. Effect of bariatric surgery on cardiac structure and function in obese patients: Role of the renin‐angiotensin system. The Journal of Clinical Hypertension 2021; 23(1): 181-192.
- Netto BDM, Bettini SC, Clemente APG, i in. Roux-en-Y gastric bypass decreases proinflammatory and thrombotic biomarkers in individuals with extreme obesity. Obes Surg 2015; 25: 1010–8.
- Masquio DC, de Piano A, Sanches PL, i in. The effect of weight loss magnitude on pro-/anti-inflammatory adipokines and carotid intima-media thickness in obese adolescents engaged in interdisciplinary weight loss therapy. Clin Endocrinol 2013; 79(1): 55–64.
- Sachan A, Singh A, Shukla S, i in. An immediate post op and follow up assessment of circulating adipo-cytokines after bariatric surgery in morbid obesity. Metabolism Open 2022; 13: 100147.
- Tabasi M, Eybpoosh S, Siadat SD, i in. Modulation of the gut microbiota and serum biomarkers after laparoscopic sleeve gastrectomy: a 1-year follow-up study. Obes Surg 2021; 31(5): 1949–56.
- Carmona-Maurici J, Cuello E, Ricart-Jane D, i in. Effect of bariatric surgery on inflammation and endothelial dysfunction as processes underlying subclinical atherosclerosis in morbid obesity. Surg Obes Relat Dis 2020; 16(12): 1961–70.
- Schmatz R, Bitencourt MR, Patias LD, i in. Evaluation of the biochemical, inflammatory and oxidative profile of obese patients given clinical treatment and bariatric surgery. Clin Chim Acta 2017; 465: 72-9.
- Villarreal-Calderon JR, Cuellar RX, Ramos-Gonzalez M, i in. Interplay between he adaptive immune system and insulin resistance in weight loss induced by bariatric surgery. Oxidative medicine and cellular longevity 2019.
- Tham JC, Howes N, le Roux CW. The role of bariatric surgery in the treatment of diabetes. Ther Adv Chronic Dis 2014; 5(3): 149–57.
